Latest News
Breaking news and real-time updates from the ASX small-cap market
G50 Corp Lifts Golconda Gallium Grades Through Low-Cost Processing
G50 Corp reports proof-of-concept at Golconda: processing upgrades gallium, recovers 63–87% into 40–60% mass; gold and silver co-products.
Alfabs Australia Posts Strong Quarterly Driven by Mining Equipment Hire Division
Alfabs Australia reports strong quarterly led by its mining equipment hire unit, with daily rates rising and debt falling on improved cashflow.
Perpetual Resources Completes Maiden Site Visit to Nevada Scheelite Tungsten Project
Perpetual Resources completes maiden Nevada Scheelite site visit; confirms infrastructure and surface skarn, with assays pending ahead of drilling targets.
EMVision Making Strong Progress with emu and First Responder Brain Scanners
EMVision advances emu brain scanner validation; recruitment milestones hit as ischaemia endpoint eyed to bolster FDA De Novo clearance and value.
D3 Energy Certifies Maiden Prospective Resource for PEL121 Permit in SA
D3 Energy certifies maiden prospective resources at SA's PEL121 (2U): 54 Bcf helium, 88 Bcf hydrogen, 226 Bcf methane; drilling planned in 2027.
Dateline Resources Confirms Widespread Rare Earths Mineralisation at Music Valley
Dateline Resources reports a 200m strike at Music Valley with TREO up to 7.1% and broad anomalous REE potential, boosting near-term exploration upside
Cyclopharm Secures 11-Site US Technegas Deployment with UH Cleveland
Cyclopharm to roll out Technegas at 11 UH Cleveland sites within weeks, expanding US footprint with immediate, recurring revenue from imaging procedures.
Nova Minerals Completes Design for Estelle Antimony Pilot Plant in Alaska
Nova Minerals completes Estelle antimony pilot plant design in Alaska; fully funded, DoW-backed, construction starts this quarter, targeting 2026/27 supply.
HeraMED Clears First Lee Health Digital Obstetrics Pilot Phase
HeraMED Phase 1 Lee Health digital obstetrics pilot validates HeraCARE; 44 patients, 92% adopt digital path; Phase 2 decision soon.
Neurotech International Granted FDA Clearance for US Paediatric Study of NTI164
Neurotech's NTI164 gets FDA IND clearance for US trial; kicks off PopPK study, paving global regulatory path ahead of potential autism therapy approvals.
Vection Technologies Signs European Smart City Framework Deal with URBANnext
Vection Technologies signs 3-year European framework with URBANnext for Algho AI, locking in at least $2.5m/year ($7.5m+ total) to smart-city deployments.
Blue Star Helium Sells First Production Tube Trailer from Pinon Canyon Processing Plant
Blue Star Helium sells its first Pinon Canyon production tube trailer; uptime improves, second trailer on-site under fixed-price offtake with a US buyer.